Advertisement

In vivo visualization of prostate-specific membrane antigen in glioblastoma

  • Johannes Schwenck
  • Ghazaleh Tabatabai
  • Marco Skardelly
  • Gerhald Reischl
  • Rudi Beschorner
  • Bernd Pichler
  • Christian la FougèreEmail author
Image of the Month

Keywords

Vascularized Tumour Tumour Vasculature Resected Tissue Treatment Concept Noninvasive Assessment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer. 2005;5:436–46. doi: 10.1038/nrc1627.PubMedCrossRefGoogle Scholar
  2. 2.
    Wernicke AG, Edgar MA, Lavi E, Liu H, Salerno P, Bander NH, et al. Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme. Arch Pathol Lab Med. 2011;135:1486–9. doi: 10.5858/arpa.2010-0740-OA.PubMedCrossRefGoogle Scholar
  3. 3.
    Tagawa ST, Milowsky MI, Morris M, Vallabhajosula S, Christos P, Akhtar NH, et al. Phase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer. Clin Cancer Res. 2013;19:5182–91. doi: 10.1158/1078-0432.CCR-13-0231.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Nomura N, Pastorino S, Jiang P, Lambert G, Crawford JR, Gymnopoulos M, et al. Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int. 2014;14:26. doi: 10.1186/1475-2867-14-26.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Eisenhut M, Linhart HG, et al. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2014;41:11–20. doi: 10.1007/s00259-013-2525-5.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Johannes Schwenck
    • 1
    • 2
  • Ghazaleh Tabatabai
    • 3
    • 4
    • 5
  • Marco Skardelly
    • 5
  • Gerhald Reischl
    • 2
  • Rudi Beschorner
    • 6
  • Bernd Pichler
    • 2
  • Christian la Fougère
    • 1
    Email author
  1. 1.Department of Nuclear Medicine and Clinical Molecular ImagingEberhard Karls UniversityTübingenGermany
  2. 2.Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging CenterEberhard Karls UniversityTübingenGermany
  3. 3.Interdisciplinary Division of Neuro-Oncology, Laboratory of Clinical and Experimental Neuro-Oncology, Hertie Institute for Clinical Brain ResearchEberhard Karls UniversityTübingenGermany
  4. 4.Department of Neurology and StrokeEberhard Karls UniversityTübingenGermany
  5. 5.Department of NeurosurgeryEberhard Karls UniversityTübingenGermany
  6. 6.Department of Pathology and NeuropathologyEberhard Karls UniversityTübingenGermany

Personalised recommendations